Connect with us


Two appointed to Tetra Pharm Technologies management board



Danish biotech company Tetra Pharm Technologies has announced the appointment of Steen Jakobsen as Chief Financial Officer (CFO) and Jacob Schlundt as Chief Marketing Officer (CMO).

The company develops and manufactures pharmaceutical drugs targeting the endocannabinoid system for the treatment of neuropathic pain, sclerosis and mental health disorders.

Tetra Pharm Technologies CEO, Martin Rose, said:

“Tetra Pharm Technologies has reached a size that makes it necessary to expand the management board.

“We are very ambitious about our future growth potential, and the expansion of the management team with experienced profiles such as Steen and Jacob, is an obvious and timely strengthening of the company.”

Jakobsen holds an MSc in Business Administration and Commercial Law from Copenhagen Business School.

He joins Tetra Pharm Technologies from Dubai’s Department of Economy and Tourism, where he held the position of Vice President.

Jakobsen has extensive experience in strategic planning, finance, and management, and he will take responsibility of the overall finance function at Tetra Pharm Technologies.

Steen Jakobsen said:

“Tetra Pharm Technologies is a very compelling company with strong values and a promising future that I am excited to be a part of.

“I look forward to contributing to the continued positive development and to accelerating our highly ambitious growth strategy in collaboration with my new colleagues.’

Shlundt holds a degree in International Business Information from Copenhagen Business College.

He joins Tetra Pharm Technologies from his role as Head of Marketing & Communications at Aon Denmark, bringing extensive experience in marketing, communications and event planning.

Jacob Schlundt said:

“I am very motivated by Tetra Pharm Technologies’ mission of developing effective and affordable drugs, and I’m excited about contributing to making a genuine difference for patients and their families.

“I’m also looking forward to developing myself personally and professionally in a team of far-sighted, competent, and dedicated.”

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending stories